Molecular Mechanisms of Medulloblastoma Development

Medulloblastoma is a highly malignant paediatric cerebellar tumour arising from aberrant developmental processes in neural progenitor cells. Four core molecular subgroups—WNT, SHH, Group 3 and Group 4—are defined by distinct genetic, epigenetic and transcriptomic profiles. Dysregulation of developmental signalling pathways, notably the Sonic hedgehog cascade and WNT–β-catenin axis, drives tumour initiation in susceptible progenitor populations. In parallel, oncogenic events such as MYC amplification, enhancer hijacking and recurrent mutations in chromatin remodellers perturb transcriptional programmes, fostering unchecked proliferation and genomic instability. Recent work has illuminated how loss of key phosphatases permits hyperphosphorylation of oncogenic regulators, while hijacking of neurodevelopmental epigenetic modules underpins metastatic dissemination. Advances in single-cell profiling and integrative machine-learning approaches have further delineated subgroup-specific regulatory circuits and stemness features, revealing how altered chromatin accessibility and DNA methylation converge to sustain self-renewal. Collectively, these insights underscore a model in which medulloblastoma co-opts normal cerebellar developmental pathways through genetic and epigenetic derangement, yielding therapeutic vulnerabilities exploitable by targeted inhibitors of kinase activity, transcription factors and epigenetic enzymes.

Research from Nature Portfolio

Recent studies have identified mutations in CTDNEP1 as a driver of aggressive MYC-amplified medulloblastomas by stabilising MYC through enhanced serine-62 phosphorylation and promoting chromosomal instability. Functional loss of CTDNEP1 in murine cerebellar progenitors accelerates tumour formation, whereas combined targeting of MYC and mitotic checkpoint kinases selectively impairs growth of CTDNEP1-deficient tumours. Complementary work reveals that aberrant activation of a SMARCD3-DAB1–Reelin epigenetic programme, normally required for Purkinje cell migration, is co-opted in metastatic medulloblastoma. This programme assembles a chromatin hub of transcription factors, EZH2 and NFIX at critical enhancer elements, driving Src kinase-dependent dissemination and exposing sensitivity to Src inhibition. Foundational whole-genome analyses have further mapped subgroup-specific driver alterations—including enhancer hijacking events and hotspot insertions—that define molecular subtypes and suggest actionable targets such as KBTBD4 and PRDM6.

Molecular Mechanisms of Medulloblastoma Development publication trend

The graph below shows the total number of articles in molecular mechanisms of medulloblastoma development across all publications each year (not limited to Nature Index journals).

Technical terms

Epigenetic regulation: Heritable modification of chromatin or DNA that controls gene expression without altering the DNA sequence.

Transcription factor: Protein that binds specific DNA sequences to regulate the transcription of genetic information.

Chromatin accessibility: Degree of openness of chromatin structure allowing regulatory proteins to access DNA.

MYC amplification: Increase in the copy number of the MYC oncogene, leading to overexpression and enhanced proliferative signalling.

Stemness: Cellular capacity for self-renewal and multipotent differentiation, characteristic of progenitor or cancer stem cells.

Sonic hedgehog pathway: Developmental signalling cascade essential for cerebellar growth, frequently dysregulated in medulloblastoma.

References

1. Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability. Nature Communications (2023).
2. A neurodevelopmental epigenetic programme mediated by SMARCD3–DAB1–Reelin signalling is hijacked to promote medulloblastoma metastasis. Nature Cell Biology (2023).
3. The whole-genome landscape of medulloblastoma subtypes. Nature (2017).
4. Single‐Cell Chromatin Accessibility Analysis Reveals Subgroup‐Specific TF‐NTR Regulatory Circuits in Medulloblastoma. Advanced Science (2024).
5. Integrative analysis of gene expression and DNA methylation through one‐class logistic regression machine learning identifies stemness features in medulloblastoma. Molecular Oncology (2019).
6. Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis. Acta Neuropathologica Communications (2019).